AhYoung Andrew P, Koehl Antoine, Vizcarra Christina L, Cascio Duilio, Egea Pascal F
Department of Biological Chemistry, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Department of Chemistry and Biochemistry, University of California at Los Angeles, Los Angeles, California.
Protein Sci. 2016 Mar;25(3):689-701. doi: 10.1002/pro.2868. Epub 2016 Jan 13.
The N-end rule pathway uses an evolutionarily conserved mechanism in bacteria and eukaryotes that marks proteins for degradation by ATP-dependent chaperones and proteases such as the Clp chaperones and proteases. Specific N-terminal amino acids (N-degrons) are sufficient to target substrates for degradation. In bacteria, the ClpS adaptor binds and delivers N-end rule substrates for their degradation upon association with the ClpA/P chaperone/protease. Here, we report the first crystal structure, solved at 2.7 Å resolution, of a eukaryotic homolog of bacterial ClpS from the malaria apicomplexan parasite Plasmodium falciparum (Pfal). Despite limited sequence identity, Plasmodium ClpS is very similar to bacterial ClpS. Akin to its bacterial orthologs, plasmodial ClpS harbors a preformed hydrophobic pocket whose geometry and chemical properties are compatible with the binding of N-degrons. However, while the N-degron binding pocket in bacterial ClpS structures is open and accessible, the corresponding pocket in Plasmodium ClpS is occluded by a conserved surface loop that acts as a latch. Despite the closed conformation observed in the crystal, we show that, in solution, Pfal-ClpS binds and discriminates peptides mimicking bona fide N-end rule substrates. The presence of an apicoplast targeting peptide suggests that Pfal-ClpS localizes to this plastid-like organelle characteristic of all Apicomplexa and hosting most of its Clp machinery. By analogy with the related ClpS1 from plant chloroplasts and cyanobacteria, Plasmodium ClpS likely functions in association with ClpC in the apicoplast. Our findings open new venues for the design of novel anti-malarial drugs aimed at disrupting parasite-specific protein quality control pathways.
N端规则途径在细菌和真核生物中使用一种进化上保守的机制,该机制通过ATP依赖的伴侣蛋白和蛋白酶(如Clp伴侣蛋白和蛋白酶)标记蛋白质以便降解。特定的N端氨基酸(N-降解子)足以将底物靶向降解。在细菌中,ClpS衔接蛋白与ClpA/P伴侣蛋白/蛋白酶结合后,会结合并递送N端规则底物进行降解。在此,我们报告了恶性疟原虫(Pfal)中细菌ClpS的真核同源物的首个晶体结构,分辨率为2.7Å。尽管序列同一性有限,但疟原虫ClpS与细菌ClpS非常相似。与其细菌直系同源物类似,疟原虫ClpS具有一个预先形成的疏水口袋,其几何形状和化学性质与N-降解子的结合相兼容。然而,虽然细菌ClpS结构中的N-降解子结合口袋是开放且可接近的,但疟原虫ClpS中的相应口袋被一个作为闩锁的保守表面环封闭。尽管在晶体中观察到封闭构象,但我们表明,在溶液中,Pfal-ClpS结合并区分模拟真正N端规则底物的肽。存在一个质体靶向肽表明Pfal-ClpS定位于所有顶复门特有的这种类质体细胞器,并承载其大部分Clp机制。与来自植物叶绿体和蓝细菌的相关ClpS1类似,疟原虫ClpS可能在质体中与ClpC协同发挥作用。我们的发现为设计旨在破坏寄生虫特异性蛋白质质量控制途径的新型抗疟药物开辟了新途径。